Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer
Open Access
- 6 September 2012
- journal article
- Published by Springer Science and Business Media LLC in Journal of Translational Medicine
- Vol. 10 (1), 186
- https://doi.org/10.1186/1479-5876-10-186
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Circulating tumor cells: advances in detection methods, biological issues, and clinical relevanceZeitschrift für Krebsforschung und Klinische Onkologie, 2011
- Cell-free nucleic acids as biomarkers in cancer patientsNature Reviews Cancer, 2011
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric CancersClinical Chemistry, 2010
- Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysisThe Lancet Oncology, 2009
- Survival prediction of gastric cancer by a seven-microRNA signatureGut, 2009
- Gastric cancer mortality trends in Spain, 1976-2005, differences by autonomous region and sexBMC Cancer, 2009
- MicroRNAs accurately identify cancer tissue originNature Biotechnology, 2008
- A microRNA expression signature of human solid tumors defines cancer gene targetsProceedings of the National Academy of Sciences of the United States of America, 2006
- MicroRNA expression profiles classify human cancersNature, 2005